Hydrocortison Fagron (Hydrocortisone)

Hydrocortison Fagron is indicated for a range of inflammatory and allergic skin conditions where a mild to moderate corticosteroid is appropriate. It is commonly employed by healthcare professionals to manage symptoms such as redness, itching, and swelling.

• Mild to moderate atopic dermatitis (eczema)
• Contact dermatitis caused by allergens or irritants
• Psoriasis plaques that require topical anti‑inflammatory therapy
• Localized allergic skin reactions, including insect bites
• Other inflammatory dermatoses as determined by a clinician

• Hydrocortison Fagron works by penetrating the epidermis and binding to intracellular glucocorticoid receptors. This receptor complex translocates to the nucleus, where it interacts with glucocorticoid response elements on DNA, altering transcription of multiple genes. The resulting changes suppress the production of pro‑inflammatory cytokines, reduce leukocyte migration, and inhibit the activity of phospholipase A2, collectively diminishing inflammation and immune responses in the skin.

Adverse reactions to topical hydrocortisone are generally limited to the area of application, but they can vary in frequency and severity.

Common

• Mild skin irritation or burning sensation at the site of application
• Transient itching or dryness
• Slight erythema or redness
• Folliculitis or acneiform eruptions
• Hypertrichosis (increased hair growth) in the treated area

Serious

• Skin atrophy or thinning with prolonged use
• Telangiectasia (visible small blood vessels)
• Secondary bacterial, fungal, or viral infection of the skin
• Hypersensitivity reactions such as contact dermatitis or urticaria
• Systemic absorption leading to adrenal suppression (rare with short‑term use)

When using Hydrocortison Fagron, certain safety considerations should be observed to minimize risk.

• Avoid application to broken, infected, or ulcerated skin unless directed by a clinician.
• Limit use on thin skin areas (e.g., face, genitalia) and on large surface areas to reduce systemic absorption.
• Do not use under occlusive dressings unless specifically prescribed.
• Discontinue if signs of allergic reaction, worsening dermatitis, or unexpected skin changes occur.
• Caution in patients with known sensitivity to corticosteroids or any component of the formulation.
• Pregnant or breastfeeding individuals should consult a healthcare professional before use.

Topical hydrocortisone can interact with other agents applied to the skin or systemic medications that affect corticosteroid metabolism.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area, which may increase the risk of skin atrophy.
• Application of topical calcineurin inhibitors (e.g., tacrolimus) on the same site without a washout period.

Use with caution

• Systemic corticosteroids, as combined effects may enhance systemic exposure.
• Antifungal or antibacterial creams that may alter skin barrier function.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs) applied topically, which could increase local irritation.
• Herbal or cosmetic products containing irritants that could exacerbate skin sensitivity.